Oct 2026· Folia Medica· Vol 68· 0 citations· 20 references
TL;DR
The findings highlight the genetic and clinical heterogeneity of MDs, emphasizing the importance of integrating molecular, biochemical, and neuroimaging data to enhance early diagnosis and facilitate personalized treatment strategies.
Abstract
Introduction
: Mitochondrial diseases (MDs) are a heterogeneous group of genetic disorders affecting oxidative phosphorylation, characterized by diverse neuromuscular and multisystemic manifestations, whose clinical variability and genetic complexity necessitate a comprehensive, multidisciplinary diagnostic approach.
Aim
: This study aims to explore the phenotypic and genotypic spectrum of patients with suspected MD, focusing on mitochondrial genome variations to improve diagnostic accuracy and support genetic counseling.
Materials and methods
: We analyzed 240 patients with a Nijmegen mitochondrial disease score (NMDS) ≥3, with 90 individuals undergoing comprehensive clinical, biochemical, neuroimaging, and genetic assessments. Descriptive statistics were applied to summarize clinical and biochemical data, while inferential analyses, including chi-square tests and regression models, were employed to explore genotype-phenotype associations.
Results
: The study delineated a multifaceted clinical spectrum, with neuromuscular dysfunction as the predominant hallmark, evidenced by a high prevalence of developmental delay (88.9%), hypotonia (77.8%), and exercise intolerance (63.3%). Patients with mitochondrial involvement displayed a significantly greater burden of neurological (seizures: 71.9% vs. 43.1%,
p
=0.009) and cardiac abnormalities (37.5% vs. 15.5%,
p
=0.018), underscoring their diagnostic relevance. Genetic analysis identified gene variants associated with the patients’ phenotypes in 35.6% of cases, with Complex I being the most frequently affected, emphasizing its pivotal role in mitochondrial dysfunction and disease severity.
Conclusion
: Our findings highlight the genetic and clinical heterogeneity of MDs, emphasizing the importance of integrating molecular, biochemical, and neuroimaging data to enhance early diagnosis and facilitate personalized treatment strategies.
Mitochondrial genetic disorders are the most common group of inherited metabolic diseases, and the eye – a tissue of exceptionally high, heterogeneous energy demand – is affected in more than half of patients, often as the presenting feature. This review synthesises current understanding of the molecular pathophysiolog...
Natalia Vladimirovna Mednikova, E. S. Yurchenko, A. Kunova et al.· Genetics and Molecular Resea...· 0 citations
The characterization of prominent VUS in OMIM-associated genes and a novel LRRK2 structural variant undetected by routine MLPA highlights the evolving complexity of PD genetics and the critical need for integrating comprehensive, read-depth-based CNV analysis into standard pipelines.
Sezin Canbek, M. F. Gulseven, Goncagül Mert et al.· Neurogenetics· 0 citations
Introduction. Neurological disorders (ND) are diseases that affect both the central nervous system (CNS) and peripheral nervous system (PNS). The aetiology of neurological disorders is highly diverse and may involve genetic, environmental, metabolic, infectious, immune-mediated, and acquired factors. Epilepsy, cerebra...
A. Gabdulkayum, Z. Mirmanova, A. Daniyarov et al.· Eurasian journal of applied...· 0 citations
Tissue-specific distribution of MT-CYB variants showed an association with clinical phenotype, while other genetic and functional factors may collectively contribute to phenotypic variability, providing further evidence for the pathogenicity of m.15045G > A.
Zi-Meng He, Tong-Yue Li, Chao-Long Xu et al.· Frontiers in Neuroscience· 0 citations
Pathogenic variants in RNU4-2, encoding for a critical component of the major spliceosome, cause a newly recognized autosomal dominant disorder. Patients with RNU4-2/ReNU syndrome exhibit global developmental delay, microcephaly, dysmorphic features, seizures, hypotonia, and multi-organ involvement. Here, we detailed c...
I. De Biase, McKall Johnson, Qin-Wen Mao et al.· Clinical Genetics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.